We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Rollover Study Protocol for Pediatric Patients in South Africa for Continued Access to Emtricitabine

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00743340
First Posted: August 28, 2008
Last Update Posted: February 23, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Gilead Sciences
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 13, 2017
  Primary Completion Date: February 13, 2017 (Final data collection date for primary outcome measure)